These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8373521)

  • 41. [Pathological changes in the cell membranes in ischemic heart disease and the possible ways for their pharmacological correction].
    Chernov IuN; Vasin MV; Batishcheva GA
    Eksp Klin Farmakol; 1994; 57(4):67-72. PubMed ID: 7950794
    [No Abstract]   [Full Text] [Related]  

  • 42. Passive and active target delivery of drugs to ischemic myocardium.
    Galagudza MM; Korolev DV; Sonin DL; Alexandrov IV; Minasian SM; Postnov VN; Kirpicheva EB; Papayan GV; Uskov IS
    Bull Exp Biol Med; 2011 Nov; 152(1):105-7. PubMed ID: 22803053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations.
    Wang X; Huang H; Zhang L; Bai Y; Chen H
    Drug Deliv; 2017 Nov; 24(1):339-345. PubMed ID: 28165817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Preparation and investigation of liposomes].
    Kása P; Gyémánt A; Kata M
    Acta Pharm Hung; 1995 Mar; 65(2):57-9. PubMed ID: 7793291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative characterization of endurance properties of ischemic myocardium in cyclic and quasistatic mechanical loads].
    Shliakhover VE; Zenin OK
    Patol Fiziol Eksp Ter; 1993; (3):28-9. PubMed ID: 8058401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mechanisms and strategies for targeting drugs to myocardial ischemic regions].
    Sun GL; Lin X
    Yao Xue Xue Bao; 2010 Jul; 45(7):827-32. PubMed ID: 20931778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting delivery of Radix Ophiopogonis polysaccharide to ischemic/reperfused rat myocardium by long-circulating macromolecular and liposomal carriers.
    Wang L; Yao C; Wu F; Lin X; Shen L; Feng Y
    Int J Nanomedicine; 2015; 10():5729-37. PubMed ID: 26425081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of liposomes with the isolated perfused rabbit heart.
    Kayawake S; Kako KJ
    Basic Res Cardiol; 1982; 77(6):668-81. PubMed ID: 6818941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Collagenase degrades collagen in vivo in the ischemic heart.
    Takahashi S; Geenen D; Nieves E; Iwazumi T
    Biochim Biophys Acta; 1999 Aug; 1428(2-3):251-9. PubMed ID: 10434043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicity.
    Galagudza MM; Korolev DV; Sonin DL; Postnov VN; Papayan GV; Uskov IS; Belozertseva AV; Shlyakhto EV
    Int J Nanomedicine; 2010 Apr; 5():231-7. PubMed ID: 20463939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uptake by rat peritoneal macrophages of 125I-labelled polyvinylpyrrolidone entrapped within liposomes.
    Pratten MK; Millard PC; Lloyd JB
    Biosci Rep; 1981 Feb; 1(2):125-33. PubMed ID: 7295889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. pH (low) insertion peptide (pHLIP) targets ischemic myocardium.
    Sosunov EA; Anyukhovsky EP; Sosunov AA; Moshnikova A; Wijesinghe D; Engelman DM; Reshetnyak YK; Andreev OA
    Proc Natl Acad Sci U S A; 2013 Jan; 110(1):82-6. PubMed ID: 23248283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines.
    Caracciolo G
    Nanomedicine; 2015 Apr; 11(3):543-57. PubMed ID: 25555353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uptake of free and liposome-entrapped 125I-labelled PVP by rat intestinal sacs in vitro: evidence for endocytosis.
    Rowland RN; Woodley JF
    Biosci Rep; 1981 May; 1(5):399-406. PubMed ID: 7295898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The mechanism of liposome accumulation in infarction.
    Palmer TN; Caride VJ; Caldecourt MA; Twickler J; Abdullah V
    Biochim Biophys Acta; 1984 Mar; 797(3):363-8. PubMed ID: 6365177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neutrophils Enable Local and Non-Invasive Liposome Delivery to Inflamed Skeletal Muscle and Ischemic Heart.
    Che J; Najer A; Blakney AK; McKay PF; Bellahcene M; Winter CW; Sintou A; Tang J; Keane TJ; Schneider MD; Shattock RJ; Sattler S; Stevens MM
    Adv Mater; 2020 Dec; 32(48):e2003598. PubMed ID: 33103807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The liposome in pharmacology.
    McCalden TA
    Proc West Pharmacol Soc; 1989; 32():101-2. PubMed ID: 2780574
    [No Abstract]   [Full Text] [Related]  

  • 58. [Distribution of harringtonine positively and negatively charged liposome in rat tissues].
    Wu HL; Weng GY; Zhou XM; Cheng DD
    Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):176-8. PubMed ID: 8352016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comments on the paper by H. Habazettl et al. The anesthetic usefulness of propanidid as a liposome dispersion].
    Sütterlin R
    Anaesthesist; 1994 Jan; 43(1):50-2. PubMed ID: 8122725
    [No Abstract]   [Full Text] [Related]  

  • 60. Possibility of targeting treatment for ischemic heart disease with liposome (I).
    Tang CS; Su JY; Li ZP; Zhang LZ; Yang J; Qi M; Liu FA; Tang J
    Sci China B; 1993 May; 36(5):590-8. PubMed ID: 8373521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.